Lyudmil Lyudmilov Todorov, MD - Medicare Anesthesiology in Pawtucket, RI

Lyudmil Lyudmilov Todorov, MD is a medicare enrolled "Anesthesiology" physician in Pawtucket, Rhode Island. He graduated from medical school in 1999 and has 25 years of diverse experience with area of expertise as Anesthesiology. He is a member of the group practice Steward Medical Group Inc and his current practice location is 111 Brewster St, Department Of Anesthesia, Pawtucket, Rhode Island. You can reach out to his office (for appointments etc.) via phone at (401) 726-7300.

Lyudmil Lyudmilov Todorov is licensed to practice in Rhode Island (license number 11775) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1477661734.

Contact Information

Lyudmil Lyudmilov Todorov, MD
111 Brewster St, Department Of Anesthesia,
Pawtucket, RI 02860-4400
(401) 726-7300
(401) 726-7330



Physician's Profile

Full NameLyudmil Lyudmilov Todorov
GenderMale
SpecialityAnesthesiology
Experience25 Years
Location111 Brewster St, Pawtucket, Rhode Island
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Lyudmil Lyudmilov Todorov graduated from medical school in 1999
  NPI Data:
  • NPI Number: 1477661734
  • Provider Enumeration Date: 08/28/2006
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 3072540434
  • Enrollment ID: I20160329001836

Medical Identifiers

Medical identifiers for Lyudmil Lyudmilov Todorov such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1477661734NPI-NPPES
412829OtherRIBLUECHIP OF RI
7057727MedicaidRI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207L00000XAnesthesiology 11775 (Rhode Island)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Morton HospitalTaunton, MAHospital
Saint Anne's HospitalFall river, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Steward Medical Group Inc28606887281404

News Archive

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug discovery - linking together generative chemistry and biology for the first time - to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ("IPF") and be validated with multiple human cell and animal model experiments.

NIH suspends funding new embryonic stem cell research following court order

"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.

Studies highlight community-based efforts to improve health of mothers and newborns in Ethiopia

A series of studies are published in a special supplement that presents results of the Maternal and Newborn Health in Ethiopia Partnership—a three-year pilot program funded by the Bill & Melinda Gates Foundation with the goal of improving the health of Ethiopian mothers and their newborns.

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.

Delayed loss of nerve cells in the brain linked to symptoms of depression following stroke

Several weeks after mild brain ischemia, mice display a depressive-like syndrome characterized by increased anxiety, inactivity and "cheerlessness". These symptoms of depression following a stroke are associated with the delayed loss of nerve cells in the brain's reward regions. This is the major finding of a study published in the current issue of Biological Psychiatry.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Lyudmil Lyudmilov Todorov allows following entities to bill medicare on his behalf.
Entity NameSteward Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629398219
PECOS PAC ID: 2860688728
Enrollment ID: O20101119000007

News Archive

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug discovery - linking together generative chemistry and biology for the first time - to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ("IPF") and be validated with multiple human cell and animal model experiments.

NIH suspends funding new embryonic stem cell research following court order

"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.

Studies highlight community-based efforts to improve health of mothers and newborns in Ethiopia

A series of studies are published in a special supplement that presents results of the Maternal and Newborn Health in Ethiopia Partnership—a three-year pilot program funded by the Bill & Melinda Gates Foundation with the goal of improving the health of Ethiopian mothers and their newborns.

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.

Delayed loss of nerve cells in the brain linked to symptoms of depression following stroke

Several weeks after mild brain ischemia, mice display a depressive-like syndrome characterized by increased anxiety, inactivity and "cheerlessness". These symptoms of depression following a stroke are associated with the delayed loss of nerve cells in the brain's reward regions. This is the major finding of a study published in the current issue of Biological Psychiatry.

Read more Medical News

› Verified 3 days ago

Entity NameSteward Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629398219
PECOS PAC ID: 2860688728
Enrollment ID: O20101119000332

News Archive

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug discovery - linking together generative chemistry and biology for the first time - to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ("IPF") and be validated with multiple human cell and animal model experiments.

NIH suspends funding new embryonic stem cell research following court order

"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.

Studies highlight community-based efforts to improve health of mothers and newborns in Ethiopia

A series of studies are published in a special supplement that presents results of the Maternal and Newborn Health in Ethiopia Partnership—a three-year pilot program funded by the Bill & Melinda Gates Foundation with the goal of improving the health of Ethiopian mothers and their newborns.

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.

Delayed loss of nerve cells in the brain linked to symptoms of depression following stroke

Several weeks after mild brain ischemia, mice display a depressive-like syndrome characterized by increased anxiety, inactivity and "cheerlessness". These symptoms of depression following a stroke are associated with the delayed loss of nerve cells in the brain's reward regions. This is the major finding of a study published in the current issue of Biological Psychiatry.

Read more Medical News

› Verified 3 days ago

Entity NameSteward Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043711914
PECOS PAC ID: 2860688728
Enrollment ID: O20180329001196

News Archive

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug discovery - linking together generative chemistry and biology for the first time - to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ("IPF") and be validated with multiple human cell and animal model experiments.

NIH suspends funding new embryonic stem cell research following court order

"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.

Studies highlight community-based efforts to improve health of mothers and newborns in Ethiopia

A series of studies are published in a special supplement that presents results of the Maternal and Newborn Health in Ethiopia Partnership—a three-year pilot program funded by the Bill & Melinda Gates Foundation with the goal of improving the health of Ethiopian mothers and their newborns.

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.

Delayed loss of nerve cells in the brain linked to symptoms of depression following stroke

Several weeks after mild brain ischemia, mice display a depressive-like syndrome characterized by increased anxiety, inactivity and "cheerlessness". These symptoms of depression following a stroke are associated with the delayed loss of nerve cells in the brain's reward regions. This is the major finding of a study published in the current issue of Biological Psychiatry.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lyudmil Lyudmilov Todorov is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Lyudmil Lyudmilov Todorov, MD
200 Main St, Suite 350,
Pawtucket, RI 02860-4119

Ph: (401) 726-7300
Lyudmil Lyudmilov Todorov, MD
111 Brewster St, Department Of Anesthesia,
Pawtucket, RI 02860-4400

Ph: (401) 726-7300

News Archive

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug discovery - linking together generative chemistry and biology for the first time - to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ("IPF") and be validated with multiple human cell and animal model experiments.

NIH suspends funding new embryonic stem cell research following court order

"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.

Studies highlight community-based efforts to improve health of mothers and newborns in Ethiopia

A series of studies are published in a special supplement that presents results of the Maternal and Newborn Health in Ethiopia Partnership—a three-year pilot program funded by the Bill & Melinda Gates Foundation with the goal of improving the health of Ethiopian mothers and their newborns.

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.

Delayed loss of nerve cells in the brain linked to symptoms of depression following stroke

Several weeks after mild brain ischemia, mice display a depressive-like syndrome characterized by increased anxiety, inactivity and "cheerlessness". These symptoms of depression following a stroke are associated with the delayed loss of nerve cells in the brain's reward regions. This is the major finding of a study published in the current issue of Biological Psychiatry.

Read more News

› Verified 3 days ago


Anesthesiology Doctors in Pawtucket, RI

Dr. Susan W Walker, MD
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 111 Brewster St, Department Of Anesthesia, Pawtucket, RI 02860
Phone: 401-726-7300    Fax: 401-726-7330
Dr. Peter E Baziotis, MD
Anesthesiology
Medicare: Not Enrolled in Medicare
Practice Location: 111 Brewster St, Anesthesia Department, Pawtucket, RI 02860
Phone: 401-726-7300    Fax: 401-726-7330
Jose Francisco De Leon, M.D.
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 200 Main St Ste 350, Anesthesia Care Inc, Pawtucket, RI 02860
Phone: 401-726-7300    
Dr. Edgardo Rodriguez, MD
Anesthesiology
Medicare: Not Enrolled in Medicare
Practice Location: 111 Brewster St, Anesthesia Department, Pawtucket, RI 02860
Phone: 401-726-7300    Fax: 401-726-7330
Ataollah Hassani Afshar, M.D.
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 200 Main St, Suite 350, Pawtucket, RI 02860
Phone: 401-726-7300    Fax: 401-726-7330

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.